Strength training induces muscle hypertrophy and functional gains in black prostate cancer patients despite androgen deprivation therapy

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 68, Issue 4, 2013, Pages 490-498

  Hanson, Erik D ^a,b   Sheaff, Andrew K ^a   Sood, Suchi ^a   Ma, Lei ^a   Francis, Jack D ^c   Goldberg, Andrew P ^d   Hurley, Ben F ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b VICTORIA UNIVERSITY   (Australia)

^c Mid Atlantic Urology Associates   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANDROGEN;

AGED; ARTICLE; BODY COMPOSITION; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; ENDURANCE; FATIGUE; FITNESS; GERIATRIC ASSESSMENT; HUMAN; MALE; METHODOLOGY; MUSCLE STRENGTH; NEGRO; PATHOPHYSIOLOGY; PHYSIOLOGY; PROSTATE TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SARCOPENIA; SKELETAL MUSCLE; STATISTICS; STRETCHING EXERCISE; TREATMENT OUTCOME; UNITED STATES;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANDROGEN ANTAGONISTS; BODY COMPOSITION; FATIGUE; GERIATRIC ASSESSMENT; HUMANS; MALE; MUSCLE STRENGTH; MUSCLE STRETCHING EXERCISES; MUSCLE, SKELETAL; PHYSICAL ENDURANCE; PHYSICAL FITNESS; PROSTATIC NEOPLASMS; QUALITY OF LIFE; SARCOPENIA; TREATMENT OUTCOME; UNITED STATES;

MLCS; MLOWN;

EID: 84875155728     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/gls206     Document Type: Article

References (38)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Moses KA, Paciorek AT, Penson DF, Carroll PR, Master VA. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE. J Clin Oncol. 2010;28:1069-1074.
3. Galvão DA, Taaffe DR, Spry N, Joseph D, Turner D, Newton RU. Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation. Prostate Cancer Prostatic Dis. 2009;12:198-203.
4. van Londen GJ, Levy ME, Perera S, Nelson JB, Greenspan SL. Body composition changes during androgen deprivation therapy for prostate cancer: a 2-year prospective study. Crit Rev Oncol Hematol. 2008;68:172-177.
5. Basaria S, Lieb J 2nd, Tang AM, et al. Long-term effects of androgen deprivation therapy in prostate cancer patients. Clin Endocrinol (Oxf). 2002;56:779-786.
6. Galvão DA, Spry NA, Taaffe DR, et al. Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer. BJU Int. 2008;102:44-47.
7. Clay CA, Perera S, Wagner JM, Miller ME, Nelson JB, Greenspan SL. Physical function in men with prostate cancer on androgen deprivation therapy. Phys Ther. 2007;87:1325-1333.
8. Levy ME, Perera S, van Londen GJ, Nelson JB, Clay CA, Greenspan SL. Physical function changes in prostate cancer patients on androgen deprivation therapy: a 2-year prospective study. Urology. 2008;71:735-739.
9. Beavers KM, Miller ME, Rejeski WJ, Nicklas BJ, Krichevsky SB. Fat Mass Loss Predicts Gain in Physical Function With Intentional Weight Loss in Older Adults. J Gerontol A Biol Sci Med Sci. 2012; Epub ahead of print.
10. Hicks GE, Shardell M, Alley DE, et al. Absolute strength and loss of strength as predictors of mobility decline in older adults: the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2012;67:66-73.
11. Dacal K, Sereika SM, Greenspan SL. Quality of life in prostate cancer patients taking androgen deprivation therapy. J Am Geriatr Soc. 2006;54:85-90.
12. Horstman AM, Dillon EL, Urban RJ, Sheffield-Moore M. The role of androgens and estrogens on Healthy Aging and Longevity. J Gerontol A Biol Sci Med Sci. 2012; Epub ahead of print.
13. Hanson ED, Hurley BF. Intervening on the side effects of hormone-dependent cancer treatment: the role of strength training. J Aging Res [Internet]. 2011; Available from http://www.ncbi.nlm.nih.gov/pmc/articles/ PMC3034975/pdf/JAR2011-903291.pdf. doi:10.4061/2011/903291.
14. Bylow K, Mohile SG, Stadler WM, Dale W. Does androgen-deprivation therapy accelerate the development of frailty in older men with prostate cancer?: a conceptual review. Cancer. 2007;110:2604-2613.
15. Hurley BF, Hanson ED, Sheaff AK. Strength training as a countermeasure to aging muscle and chronic disease. Sports Med. 2011;41:289-306.
16. Hanson ED, Srivatsan SR, Agrawal S, et al. Effects of strength training on physical function: influence of power, strength, and body composition. J Strength Cond Res. 2009;23:2627-2637.
17. Delmonico MJ, Kostek MC, Doldo NA, et al. Effects of moderatevelocity strength training on peak muscle power and movement velocity: do women respond differently than men? J Appl Physiol. 2005;99:1712-1718.
18. Walts CT, Hanson ED, Delmonico MJ, Yao L, Wang MQ, Hurley BF. Do sex or race differences influence strength training effects on muscle or fat? Med Sci Sports Exerc. 2008;40:669-676.
19. Galvão DA, Taaffe DR. Resistance exercise dosage in older adults: single- versus multiset effects on physical performance and body composition. J Am Geriatr Soc. 2005;53:2090-2097.
20. Segal RJ, Reid RD, Courneya KS, et al. Resistance exercise in men receiving androgen deprivation therapy for prostate cancer. J Clin Oncol. 2003;21:1653-1659.
21. Galvão DA, Nosaka K, Taaffe DR, et al. Resistance training and reduction of treatment side effects in prostate cancer patients. Med Sci Sports Exerc. 2006;38:2045-2052.
22. Alberga AS, Segal RJ, Reid RD, et al. Age and androgen-deprivation therapy on exercise outcomes in men with prostate cancer. Support Care Cancer. 2012;20:971-981.
23. Kvorning T, Andersen M, Brixen K, Madsen K. Suppression of endogenous testosterone production attenuates the response to strength training: a randomized, placebo-controlled, and blinded intervention study. Am J Physiol Endocrinol Metab. 2006;291:E1325-E1332.
24. Hansen PA, Dechet CB, Porucznik CA, LaStayo PC. Comparing eccentric resistance exercise in prostate cancer survivors on and off hormone therapy: a pilot study. PM R. 2009;1:1019-1024.
25. Mohler JL, Gaston KE, Moore DT, et al. Racial differences in prostate androgen levels in men with clinically localized prostate cancer. J Urol. 2004;171(6 Pt 1):2277-2280.
26. O lapade-Olaopa EO, Muronda CA, MacKay EH, et al. Androgen receptor protein expression in prostatic tissues in Black and Caucasian men. Prostate. 2004;59:460-468.
27. Reid KF, Fielding RA. Skeletal muscle power: a critical determinant of physical functioning in older adults. Exerc Sport Sci Rev. 2012;40:4-12.
28. Tracy BL, Ivey FM, Jeffrey Metter E, Fleg JL, Siegel EL, Hurley BF. A more efficient magnetic resonance imaging-based strategy for measuring quadriceps muscle volume. Med Sci Sports Exerc. 2003;35:425-433.
29. Basaria S, Collins L, Dillon EL, et al. The Safety, Pharmacokinetics, and Effects of LGD-4033, a Novel Nonsteroidal Oral, Selective Androgen Receptor Modulator, in Healthy Young Men. J Gerontol A Biol Sci Med Sci. 2012; Epub ahead of print. doi:10.1093/gerona/gls078.
30. Mazer NA. A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations. Steroids. 2009;74:512-519.
31. Bhasin S, Pencina M, Jasuja GK, et al. Reference ranges for testosterone in men generated using liquid chromatography tandem mass spectrometry in a community-based sample of healthy nonobese young men in the Framingham Heart Study and applied to three geographically distinct cohorts. J Clin Endocrinol Metab. 2011;96:2430-2439.
32. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Acute versus chronic exposure to androgen suppression for prostate cancer: impact on the exercise response. J Urol. 2011;186:1291-1297.
33. Segal RJ, Reid RD, Courneya KS, et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J Clin Oncol. 2009;27:344-351.
34. Galvão DA, Taaffe DR, Spry N, Joseph D, Newton RU. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol. 2010;28:340-347.
35. West DW, Burd NA, Tang JE, et al. Elevations in ostensibly anabolic hormones with resistance exercise enhance neither training-induced muscle hypertrophy nor strength of the elbow flexors. J Appl Physiol. 2010;108:60-67.
36. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L. A comparison of leg power and leg strength within the InCHIANTI study: which influences mobility more? J Gerontol A Biol Sci Med Sci. 2003;58:728-733.
37. Cuoco A, Callahan DM, Sayers S, Frontera WR, Bean J, Fielding RA. Impact of muscle power and force on gait speed in disabled older men and women. J Gerontol A Biol Sci Med Sci. 2004;59:1200-1206.
38. Mangione KK, Craik RL, McCormick AA, et al. Detectable changes in physical performance measures in elderly African Americans. Phys Ther. 2010;90:921-927.